Approval typically means the medication is covered according to your plan's benefits
Internally one may have a circulatory system in better shape, biologically younger than another person of the same age with degenerative circulatory disease
When to seek medical advice : Patients should contact their GP or diabetes specialist nurse if they experience: Severe, persistent vomiting preventing adequate fluid intake (risk of dehydration and acute kidney injury) Severe abdominal pain, particularly if radiating to the back (potential pancreatitisrare but serious) Right upper abdominal pain, fever, or yellowing of skin/eyes (potential gallbladder disease) Sudden vision changes (particularly with semaglutide, which may worsen diabetic retinopathy, especially with rapid HbA1c reduction) [40] [41] Signs of hypoglycaemia when used with insulin or sulphonylureas Allergic reactions (rash, difficulty breathing, facial swelling)call 999 or go to A&E for severe allergic reactions Patients should report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
The 2.4mg cagrilintide + 2.4mg semaglutide mix produced the best results, with average weight loss of about 17-18% over 32 weeks compared to 10-11% with semaglutide 2.4mg alone
Wegovy Prescribing Information
Klausen MK et al
